By Pat Broderick
Daily Journal Staff Writer
SAN DIEGO - Del Mar-based Adamis Pharmaceuticals Corp. has entered into a definitive merger agreement to acquire La Jolla Pharmaceutical Co., expected to close by the first quarter of 2010. La Jolla Pharmaceutical anticipates about $3 million in cash to be left in the company at the time of the merger, while La Jolla stockholders could hold up to 30 percent of the outstanding shares of the combined...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In